MeSH term
Frequency | Condition_Probility | Amino Acid Sequence | 13 | 0.0 |
Animals | 42 | 0.0 |
Cell Line | 11 | 0.0 |
DNA-Binding Proteins/*metabolism | 3 | 0.0 |
*Gene Expression Regulation, Developmental | 3 | 0.0 |
Homeodomain Proteins/*metabolism | 3 | 2.0 |
Humans | 60 | 0.0 |
Mice | 35 | 0.0 |
Molecular Sequence Data | 21 | 0.0 |
Promoter Regions (Genetics) | 7 | 0.0 |
Rats | 5 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 27 | 0.0 |
Sequence Alignment | 6 | 0.0 |
Transcription Factors/*metabolism | 3 | 0.0 |
*Transcription, Genetic | 8 | 0.0 |
Research Support, Non-U.S. Gov't | 47 | 0.0 |
*Zebrafish Proteins | 2 | 0.0 |
Base Sequence | 18 | 0.0 |
DNA/chemistry/metabolism | 2 | 2.0 |
Down-Regulation | 3 | 0.0 |
Genes, Reporter | 3 | 0.0 |
Protein Binding | 4 | 0.0 |
Protein Structure, Tertiary | 3 | 0.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
Time Factors | 2 | 0.0 |
Trans-Activation (Genetics) | 2 | 0.0 |
Transcription, Genetic | 5 | 0.0 |
Transfection | 4 | 0.0 |
DNA, Complementary/metabolism | 2 | 0.0 |
Gene Expression Regulation | 6 | 0.0 |
Mutation | 7 | 0.0 |
*Neoplasm Proteins | 6 | 0.0 |
Nuclear Proteins/*metabolism | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 4 | 0.0 |
Dogs | 2 | 0.0 |
Mutation/genetics | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 4 | 0.0 |
Transcription Factors/genetics/*metabolism | 3 | 0.0 |
Bone Development/*genetics | 2 | 14.0 |
Gene Expression Regulation, Developmental | 8 | 0.0 |
Signal Transduction | 3 | 0.0 |
Transcription Factors/genetics | 8 | 0.0 |
Cell Movement/physiology | 2 | 0.0 |
DNA-Binding Proteins/genetics/*metabolism | 2 | 0.0 |
Embryonic and Fetal Development | 4 | 1.0 |
Gene Targeting | 2 | 0.0 |
Heart/*embryology | 2 | 3.0 |
Homeodomain Proteins/genetics/metabolism | 2 | 2.0 |
Mice, Inbred BALB C | 3 | 0.0 |
Mice, Inbred C57BL | 4 | 0.0 |
Mice, Transgenic | 6 | 0.0 |
Cell Differentiation | 5 | 0.0 |
Craniosynostoses/genetics | 3 | 33.0 |
Homeodomain Proteins/genetics/*metabolism | 2 | 1.0 |
Osteoblasts/cytology/drug effects/metabolism | 2 | 33.0 |
Point Mutation | 5 | 0.0 |
Adenoviridae/genetics | 2 | 0.0 |
Cell Differentiation/physiology | 2 | 0.0 |
Cells, Cultured | 4 | 0.0 |
DNA-Binding Proteins/*genetics | 13 | 0.0 |
*Extracellular Matrix Proteins | 2 | 1.0 |
Chromosome Mapping | 7 | 0.0 |
Crosses, Genetic | 2 | 0.0 |
Disease Models, Animal | 3 | 0.0 |
Female | 18 | 0.0 |
Genetic Markers | 3 | 0.0 |
Genotype | 5 | 0.0 |
Linkage (Genetics) | 3 | 0.0 |
Male | 14 | 0.0 |
Models, Genetic | 2 | 0.0 |
Neural Tube Defects/*genetics | 2 | 5.0 |
*Gene Expression Regulation | 2 | 0.0 |
Homeodomain Proteins/*genetics/physiology | 2 | 7.0 |
*Genes, Homeobox | 9 | 4.0 |
Sequence Homology, Amino Acid | 3 | 0.0 |
Species Specificity | 2 | 0.0 |
Apoptosis/*physiology | 3 | 0.0 |
Conserved Sequence | 2 | 0.0 |
Mice, Knockout | 2 | 0.0 |
*Osteogenesis | 2 | 8.0 |
*Transcription Factors | 10 | 0.0 |
Exons | 2 | 0.0 |
Gene Deletion | 2 | 0.0 |
*Mutation | 7 | 0.0 |
Pedigree | 9 | 0.0 |
Polymorphism, Genetic | 2 | 0.0 |
Polymorphism, Single-Stranded Conformational | 2 | 0.0 |
Transcription Factors/*genetics | 3 | 0.0 |
Craniosynostoses/*genetics | 4 | 11.0 |
Homeodomain Proteins/genetics | 4 | 1.0 |
Morphogenesis | 3 | 1.0 |
*Nuclear Proteins | 2 | 0.0 |
*Protein-Tyrosine Kinase | 3 | 0.0 |
DNA-Binding Proteins/genetics/*physiology | 4 | 1.0 |
Transcription Factors/genetics/*physiology | 3 | 1.0 |
Cell Differentiation/drug effects | 2 | 0.0 |
DNA-Binding Proteins/genetics | 7 | 0.0 |
Growth Substances/genetics | 2 | 3.0 |
In Situ Hybridization | 7 | 0.0 |
*Transforming Growth Factor beta | 2 | 1.0 |
Cloning, Molecular | 3 | 0.0 |
Tissue Distribution | 3 | 0.0 |
Tumor Cells, Cultured | 3 | 0.0 |
Child | 3 | 0.0 |
Child, Preschool | 4 | 0.0 |
Craniosynostoses/*genetics/pathology | 2 | 33.0 |
Family Health | 2 | 0.0 |
Haplotypes | 2 | 0.0 |
Infant | 3 | 0.0 |
Microsatellite Repeats | 4 | 0.0 |
Syndrome | 5 | 0.0 |
DNA Mutational Analysis | 5 | 0.0 |
Homeodomain Proteins/*genetics | 7 | 1.0 |
Models, Biological | 2 | 0.0 |
Pregnancy | 2 | 0.0 |
Cell Division | 3 | 0.0 |
Mice, Mutant Strains | 3 | 0.0 |
Phenotype | 6 | 0.0 |
Adult | 5 | 0.0 |
Osteogenesis/*genetics | 2 | 20.0 |
*Chromosomes, Human, Pair 5 | 3 | 1.0 |
In Situ Hybridization, Fluorescence | 3 | 0.0 |
Cell Lineage | 2 | 0.0 |
DNA Primers | 2 | 0.0 |
Osteocalcin/*genetics | 3 | 13.0 |
Gene Expression | 7 | 0.0 |
Comparative Study | 3 | 0.0 |
Gene Expression Regulation/genetics | 2 | 1.0 |
Zinc Fingers | 2 | 0.0 |
Culture Techniques | 2 | 0.0 |
Morphogenesis/genetics | 3 | 7.0 |
Nuclear Proteins/genetics | 2 | 0.0 |
Proteins/genetics | 2 | 0.0 |
Receptors, Fibroblast Growth Factor/genetics | 3 | 4.0 |
Signal Transduction/genetics | 3 | 1.0 |
*Trans-Activators | 2 | 0.0 |
*Xenopus Proteins | 3 | 0.0 |
Mice, Inbred CBA | 2 | 0.0 |
Bone Morphogenetic Proteins/pharmacology | 2 | 6.0 |
Middle Aged | 3 | 0.0 |
Mice, Inbred Strains | 2 | 0.0 |
Organ Culture Techniques | 2 | 0.0 |
RNA, Messenger/analysis | 2 | 0.0 |
Signal Transduction/*physiology | 2 | 0.0 |
Receptor Protein-Tyrosine Kinases/genetics | 2 | 1.0 |
Osteoblasts/*metabolism | 2 | 3.0 |
Structure-Activity Relationship | 2 | 0.0 |
DNA-Binding Proteins/*genetics/metabolism | 2 | 0.0 |
Embryo | 2 | 0.0 |
Genes, Homeobox | 5 | 5.0 |
Infant, Newborn | 2 | 0.0 |
Recombinant Proteins/pharmacology | 2 | 0.0 |
Apoptosis | 2 | 0.0 |
Chromosomes, Artificial, Yeast | 2 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Extremities/embryology | 2 | 5.0 |
Lod Score | 3 | 0.0 |
Proline | 2 | 3.0 |
Cleft Lip/embryology | 2 | 100.0 |
Cleft Palate/embryology | 2 | 66.0 |
Growth Substances/physiology | 2 | 1.0 |
Gene Expression Regulation, Developmental/*physiology | 2 | 1.0 |
DNA-Binding Proteins/metabolism | 2 | 0.0 |
Up-Regulation | 2 | 0.0 |
